Menu Close
  • Resources
  • Publications
  • Levetiracetam Pregnancy Registry: Final Results and a Review of the Impact of Registry Methodology and Definitions on the Prevalence of Major Congenital Malformations

Levetiracetam Pregnancy Registry: Final Results and a Review of the Impact of Registry Methodology and Definitions on the Prevalence of Major Congenital Malformations

Citation

Scheuerle, Angela E.; Holmes, Lewis B.; Albano, Jessica D.; Badalamenti, Vincent; Battino, Dina; Covington, Deborah L.; Harden, Cynthia; Miller, David; Montouris, Georgia D.; & Pantaleoni, Chiara, et al. (2019). Levetiracetam Pregnancy Registry: Final Results and a Review of the Impact of Registry Methodology and Definitions on the Prevalence of Major Congenital Malformations. Birth Defects Research, 111(13), 872-87.

Abstract

BACKGROUND: To evaluate pregnancy outcomes among women participating in the antiepileptic drug (AED) Levetiracetam Registry (LEV-Registry), and to review the impact of using two other registries' outcome definitions on the number of major congenital malformations (MCMs).

URL

http://dx.doi.org/10.1002/bdr2.1526

Reference Type

Journal Article

Journal Title

Birth Defects Research

Author(s)

Scheuerle, Angela E.
Holmes, Lewis B.
Albano, Jessica D.
Badalamenti, Vincent
Battino, Dina
Covington, Deborah L.
Harden, Cynthia
Miller, David
Montouris, Georgia D.
Pantaleoni, Chiara
Thorp, John M., Jr.
Tofighy, Azita
Tomson, Torbjörn
Golembesky, Amanda K.

Year Published

2019

Volume Number

111

Issue Number

13

Pages

872-87

Reference ID

13019